Smart Syringe Market Report 2025

The smart syringe market size has grown strongly in recent years. It will grow from $11.14 billion in 2024 to $12.25 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to need for medication safety, prevalence of blood-borne diseases, regulatory compliance, global immunization programs, increased healthcare awareness.

The smart syringe market size is expected to see rapid growth in the next few years. It will grow to $19.33 billion in 2029 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to global vaccination initiatives, prevention of medication errors, rise in chronic diseases, expansion of home healthcare, government healthcare initiatives. Major trends in the forecast period include collaborations and partnerships, regulatory compliance, adoption in vaccination programs, focus on sustainable materials, expansion in emerging markets.

Increasing healthcare expenditure is anticipated to drive the growth of the smart syringes market in the coming years. Healthcare expenditure represents the total resources, usually quantified in monetary terms, that a country, organization, or individual dedicates to healthcare services and products. This rise in spending is influenced by various factors, including an aging population, the prevalence of chronic diseases, advancements in medical technology, and growing consumer expectations for high-quality care. The smart syringes market aligns with this increased expenditure by offering innovative solutions that enhance patient safety, improve procedural efficiency, and lower healthcare costs related to complications from traditional syringes. For example, in November 2023, the Canadian Institute for Health Information, a non-profit organization, projected total health spending in Canada to reach $344 billion for the year, a 2.8% increase over the prior year. Thus, the growth in healthcare expenditure is fueling the expansion of the smart syringes market.

The rising prevalence of blood-borne diseases is expected to drive the growth of the smart syringes market in the coming years. Blood-borne diseases are infections caused by pathogens transmitted through contact with infected blood or bodily fluids. Smart syringes offer an effective tool in combating these diseases, featuring a mechanism that automatically disables the plunger after a single use, thus reducing the risk of accidental needle sticks. For example, in April 2024, the Centers for Disease Control and Prevention (CDC), a U.S.-based public health agency, reported 2,126 acute hepatitis B cases in 2022, equating to an estimated 13,800 infections after accounting for underreporting. This marks an increase from 2021, which had 2,045 reported cases and approximately 13,300 estimated infections. Consequently, the growing prevalence of blood-borne diseases is fueling the expansion of the smart syringes market.

Product innovations are increasingly popular in the smart syringes market, as major companies introduce new products like safety syringes to enhance patient safety, minimize needlestick injury risks, and boost procedural efficiency. Safety syringes are specifically designed to lower the chance of needlestick injuries and prevent syringe reuse. For instance, in April 2024, Hindustan Syringes and Medical Devices, an India-based medical device company, launched Dispojekt Syringes, a safety syringe designed to enhance safety in healthcare settings. Dispojekt features a transparent, one-hand-operable safety mechanism to reduce accidental needlestick injuries (NSIs), a common source of blood-borne disease transmission among healthcare professionals. The syringe also includes a molded plastic safety shield to prevent blood splatter during use, fostering a safer environment for both patients and healthcare workers. By addressing critical safety and infection control concerns, Dispojekt reflects HMD's commitment to quality and innovation, supporting India's goal of becoming a global leader in medical manufacturing.

Companies at the forefront of the smart syringes market are actively investing in technological advancements, incorporating innovations such as Near Field Communication (NFC) technology to gain a competitive advantage. NFC is a short-range wireless communication technology facilitating contactless data exchange between devices. NP Plastibell, a France-based medical device manufacturer, exemplifies this trend with the launch of its Pre-filled Smart Syringe in May 2022. This smart syringe incorporates an embedded NFC chip that transmits essential information about the medication to both practitioners and patients. The NFC chip stores crucial details, including drug name, dosage, expiration date, and lot number, allowing easy access through smartphones or other NFC-enabled devices.

In July 2022, Sharps Technology, a prominent US-based medical device manufacturer, acquired Safeguard Medical's smart syringes manufacturing facility for $2.5 million. This acquisition is aimed at expanding Sharps' manufacturing capabilities to meet the rising demand for smart syringes. Safeguard Medical, a US-based manufacturer specializing in smart syringes and emergency medical technologies, contributes to Sharps Technology's growth strategy in this dynamic market landscape.

Major companies operating in the smart syringe market include Becton Dickinson and Company, Gerresheimer AG, Baxter International Inc., Terumo Corporation, Braun Melsungen AG, Cardinal Health Inc., Smiths Medical Inc, Retractable Technologies Inc., AdvaCare Pharma, Numedico Technologies Pty Ltd., Merit Medical Systems Inc., Nipro Corporation, Revolutions Medical Corporation, Sharps Technology, West Pharmaceutical Services Inc., Schott AG, Vetter Pharma International GmbH, Catalent Inc., Thermo Fisher Scientific Inc., Haselmeier GmbH, Owen Mumford Ltd., Ypsomed Holding AG, Weigao Group, Jiangsu Huida Medical Instruments Co. Ltd., Shandong Weigao Group Medical Polymer Co. Ltd.

North America was the largest region in the global smart syringes market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smart syringe market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the smart syringe market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Smart syringes represent cutting-edge medical devices that integrate technology to enhance the safety, precision, and efficiency of administering injections. These innovative syringes effectively address critical concerns such as needlestick injuries, medication errors, and the transmission of bloodborne diseases, thereby significantly improving both patient and healthcare provider safety.

The primary categories of smart syringes include auto-disable syringes, active safety syringes, and passive safety syringes. Auto-disable syringes are specifically engineered to prevent reuse after a single injection. Widely employed in immunization campaigns, these syringes automatically lock after a single use, ensuring the secure and contamination-free delivery of doses. This versatile solution caters to various segments, including pediatrics and adults, and finds applications in drug delivery, vaccination, and blood specimen collection. Auto-disable syringes are utilized across diverse industries, including hospitals, health maintenance organizations (HMOs), diabetic patient care, family practices (physicians), psychiatry, and more.

The smart syringes market research report is one of a series of new reports that provides smart syringes market statistics, including smart syringes industry global market size, regional shares, competitors with a smart syringes market share, detailed smart syringes market segments, market trends, and opportunities, and any further data you may need to thrive in the smart syringes industry. These smart syringes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The smart syringes market consists of sales of exchangeable needle syringes and fixed needle syringes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.